Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Breast cancer stem cell-like cells are more sensitive to ionizing radiation than non-stem cells: role of ATM.

PloS one | 2012

There are contradictory observations about the different radiosensitivities of cancer stem cells and cancer non-stem cells. To resolve these contradictory observations, we studied radiosensitivities by employing breast cancer stem cell (CSC)-like MDA-MB231 and MDA-MB453 cells as well as their corresponding non-stem cells. CSC-like cells proliferate without differentiating and have characteristics of tumor-initiating cells [1]. These cells were exposed to γ-rays (1.25-8.75 Gy) and survival curves were determined by colony formation. A final slope, D(0), of the survival curve for each cell line was determined to measure radiosensitivity. The D(0) of CSC-like and non-stem MDA-MB-453 cells were 1.16 Gy and 1.55 Gy, respectively. Similar results were observed in MDA-MB-231 cells (0.94 Gy vs. 1.56 Gy). After determination of radiosensitivity, we investigated intrinsic cellular determinants which influence radiosensitivity including cell cycle distribution, free-radical scavengers and DNA repair. We observed that even though cell cycle status and antioxidant content may contribute to differential radiosensitivity, differential DNA repair capacity may be a greater determinant of radiosensitivity. Unlike non-stem cells, CSC-like cells have little/no sublethal damage repair, a low intracellular level of ataxia telangiectasia mutated (ATM) and delay of γ-H2AX foci removal (DNA strand break repair). These results suggest that low DNA repair capacity is responsible for the high radiosensitivity of these CSC-like cells.

Pubmed ID: 23185620 RIS Download

Research resources used in this publication

None found

Antibodies used in this publication

None found

Associated grants

  • Agency: NCI NIH HHS, United States
    Id: BC103217
  • Agency: NCI NIH HHS, United States
    Id: R01 CA133114
  • Agency: NCI NIH HHS, United States
    Id: P30 CA086862
  • Agency: NCI NIH HHS, United States
    Id: R01 CA140554
  • Agency: NCI NIH HHS, United States
    Id: R01 CA094858
  • Agency: NCI NIH HHS, United States
    Id: NIH R01CA133114
  • Agency: NCI NIH HHS, United States
    Id: R01 CA100045
  • Agency: NCI NIH HHS, United States
    Id: R01 CA116430
  • Agency: NCI NIH HHS, United States
    Id: R01 CA121904
  • Agency: NCI NIH HHS, United States
    Id: NIH P30 CA086862
  • Agency: NCI NIH HHS, United States
    Id: R01 CA123484

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


ImageQuant (tool)

RRID:SCR_014246

Software for automatic general image analysis. It provides fully automatic analysis of 1-D gels including lane creation, background subtraction, band detection, molecular weight calibration, quantity calibration, and normalization. Editing tools are provided for cropping, rotating, and filtering images.

View all literature mentions

MDA-MB-435 (tool)

RRID:CVCL_0417

Cell line MDA-MB-435 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

MDA-MB-453 (tool)

RRID:CVCL_0418

Cell line MDA-MB-453 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

MDA-MB-231 (tool)

RRID:CVCL_0062

Cell line MDA-MB-231 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions